APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Montelukast Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Montelukast Drug Market Analysis and Forecast 2026-2032

Report ID 174014240220 December 2025219 pages

Choose your research edition.

Industry ResearchMontelukast Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast Drug Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Montelukast Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast Drug Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast Drug Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Montelukast Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Montelukast Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Montelukast Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Montelukast Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Montelukast Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Montelukast Drug include Teva, Sandoz, Merck & Co., Mylan, Unimark, Unichem Laboratories, Torrent Pharmaceuticals, Shanghai Anbison Lab and Perrigo, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Montelukast Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Montelukast Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Montelukast Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Montelukast Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Montelukast Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Montelukast Drug sales, projected growth trends, production technology, application and end-user industry.

Montelukast Drug Segment by Company

Teva

Sandoz

Merck & Co.

Mylan

Unimark

Unichem Laboratories

Torrent Pharmaceuticals

Shanghai Anbison Lab

Perrigo

MACLEODS

Lannett Company

Jubilant Pharma

Hikma Group

Hetero

Glenmark Pharmaceuticals

Dr. Reddys Laboratories

CSPC Ouyi Pharmaceutical

Cipla

Aurobindo Pharma

Apotex

Amneal Pharmaceuticals

Ajanta Pharma

Accord Healthcare

Montelukast Drug Segment by Type

Tablets

Oral Granules

Montelukast Drug Segment by Application

Hospital

Drug Store

Others

Montelukast Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Montelukast Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Montelukast Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Montelukast Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Montelukast Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablets Major Manufacturers Table 3. Oral Granules Major Manufacturers Table 4. Global Montelukast Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Drug Store Major Manufacturers Table 7. Others Major Manufacturers Table 8. Montelukast Drug Industry Trends Table 9. Montelukast Drug Industry Drivers Table 10. Montelukast Drug Industry Opportunities and Challenges Table 11. Montelukast Drug Industry Restraints Table 12. Global Montelukast Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Montelukast Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Montelukast Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Montelukast Drug Revenue Market Share by Region (2021-2026) Table 16. Global Montelukast Drug Revenue Market Share by Region (2027-2032) Table 17. Global Montelukast Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 18. Global Montelukast Drug Sales by Region (2021-2026) & (W Units) Table 19. Global Montelukast Drug Sales by Region (2027-2032) & (W Units) Table 20. Global Montelukast Drug Sales Market Share by Region (2021-2026) Table 21. Global Montelukast Drug Sales Market Share by Region (2027-2032) Table 22. Global Montelukast Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Montelukast Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Montelukast Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Montelukast Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global Montelukast Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Montelukast Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Montelukast Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Montelukast Drug Manufacturers, Product Type & Application Table 30. Global Montelukast Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Montelukast Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Montelukast Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Montelukast Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Montelukast Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Montelukast Drug Revenue Market Share by Type (2021-2026) Table 37. Global Montelukast Drug Revenue Market Share by Type (2027-2032) Table 38. Global Montelukast Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 39. Global Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 40. Global Montelukast Drug Sales by Type (2027-2032) & (W Units) Table 41. Global Montelukast Drug Sales Market Share by Type (2021-2026) Table 42. Global Montelukast Drug Sales Market Share by Type (2027-2032) Table 43. Global Montelukast Drug Price by Type (2021-2026) & (US$/Unit) Table 44. Global Montelukast Drug Price by Type (2027-2032) & (US$/Unit) Table 45. Global Montelukast Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Montelukast Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Montelukast Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Montelukast Drug Revenue Market Share by Application (2021-2026) Table 49. Global Montelukast Drug Revenue Market Share by Application (2027-2032) Table 50. Global Montelukast Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 51. Global Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 52. Global Montelukast Drug Sales by Application (2027-2032) & (W Units) Table 53. Global Montelukast Drug Sales Market Share by Application (2021-2026) Table 54. Global Montelukast Drug Sales Market Share by Application (2027-2032) Table 55. Global Montelukast Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Montelukast Drug Price by Application (2027-2032) & (US$/Unit) Table 57. Teva Company Information Table 58. Teva Business Overview Table 59. Teva Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Teva Montelukast Drug Product Portfolio Table 61. Teva Recent Development Table 62. Sandoz Company Information Table 63. Sandoz Business Overview Table 64. Sandoz Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Sandoz Montelukast Drug Product Portfolio Table 66. Sandoz Recent Development Table 67. Merck & Co. Company Information Table 68. Merck & Co. Business Overview Table 69. Merck & Co. Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Merck & Co. Montelukast Drug Product Portfolio Table 71. Merck & Co. Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Mylan Montelukast Drug Product Portfolio Table 76. Mylan Recent Development Table 77. Unimark Company Information Table 78. Unimark Business Overview Table 79. Unimark Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Unimark Montelukast Drug Product Portfolio Table 81. Unimark Recent Development Table 82. Unichem Laboratories Company Information Table 83. Unichem Laboratories Business Overview Table 84. Unichem Laboratories Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Unichem Laboratories Montelukast Drug Product Portfolio Table 86. Unichem Laboratories Recent Development Table 87. Torrent Pharmaceuticals Company Information Table 88. Torrent Pharmaceuticals Business Overview Table 89. Torrent Pharmaceuticals Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Torrent Pharmaceuticals Montelukast Drug Product Portfolio Table 91. Torrent Pharmaceuticals Recent Development Table 92. Shanghai Anbison Lab Company Information Table 93. Shanghai Anbison Lab Business Overview Table 94. Shanghai Anbison Lab Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Shanghai Anbison Lab Montelukast Drug Product Portfolio Table 96. Shanghai Anbison Lab Recent Development Table 97. Perrigo Company Information Table 98. Perrigo Business Overview Table 99. Perrigo Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Perrigo Montelukast Drug Product Portfolio Table 101. Perrigo Recent Development Table 102. MACLEODS Company Information Table 103. MACLEODS Business Overview Table 104. MACLEODS Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. MACLEODS Montelukast Drug Product Portfolio Table 106. MACLEODS Recent Development Table 107. Lannett Company Company Information Table 108. Lannett Company Business Overview Table 109. Lannett Company Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Lannett Company Montelukast Drug Product Portfolio Table 111. Lannett Company Recent Development Table 112. Jubilant Pharma Company Information Table 113. Jubilant Pharma Business Overview Table 114. Jubilant Pharma Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Jubilant Pharma Montelukast Drug Product Portfolio Table 116. Jubilant Pharma Recent Development Table 117. Hikma Group Company Information Table 118. Hikma Group Business Overview Table 119. Hikma Group Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Hikma Group Montelukast Drug Product Portfolio Table 121. Hikma Group Recent Development Table 122. Hetero Company Information Table 123. Hetero Business Overview Table 124. Hetero Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Hetero Montelukast Drug Product Portfolio Table 126. Hetero Recent Development Table 127. Glenmark Pharmaceuticals Company Information Table 128. Glenmark Pharmaceuticals Business Overview Table 129. Glenmark Pharmaceuticals Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Glenmark Pharmaceuticals Montelukast Drug Product Portfolio Table 131. Glenmark Pharmaceuticals Recent Development Table 132. Dr. Reddys Laboratories Company Information Table 133. Dr. Reddys Laboratories Business Overview Table 134. Dr. Reddys Laboratories Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Dr. Reddys Laboratories Montelukast Drug Product Portfolio Table 136. Dr. Reddys Laboratories Recent Development Table 137. CSPC Ouyi Pharmaceutical Company Information Table 138. CSPC Ouyi Pharmaceutical Business Overview Table 139. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolio Table 141. CSPC Ouyi Pharmaceutical Recent Development Table 142. Cipla Company Information Table 143. Cipla Business Overview Table 144. Cipla Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Cipla Montelukast Drug Product Portfolio Table 146. Cipla Recent Development Table 147. Aurobindo Pharma Company Information Table 148. Aurobindo Pharma Business Overview Table 149. Aurobindo Pharma Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Aurobindo Pharma Montelukast Drug Product Portfolio Table 151. Aurobindo Pharma Recent Development Table 152. Apotex Company Information Table 153. Apotex Business Overview Table 154. Apotex Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Apotex Montelukast Drug Product Portfolio Table 156. Apotex Recent Development Table 157. Amneal Pharmaceuticals Company Information Table 158. Amneal Pharmaceuticals Business Overview Table 159. Amneal Pharmaceuticals Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Amneal Pharmaceuticals Montelukast Drug Product Portfolio Table 161. Amneal Pharmaceuticals Recent Development Table 162. Ajanta Pharma Company Information Table 163. Ajanta Pharma Business Overview Table 164. Ajanta Pharma Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Ajanta Pharma Montelukast Drug Product Portfolio Table 166. Ajanta Pharma Recent Development Table 167. Accord Healthcare Company Information Table 168. Accord Healthcare Business Overview Table 169. Accord Healthcare Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Accord Healthcare Montelukast Drug Product Portfolio Table 171. Accord Healthcare Recent Development Table 172. North America Montelukast Drug Revenue by Type (2021-2026) & (US$ Million) Table 173. North America Montelukast Drug Revenue by Type (2027-2032) & (US$ Million) Table 174. North America Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 175. North America Montelukast Drug Sales by Type (2027-2032) & (W Units) Table 176. North America Montelukast Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 177. North America Montelukast Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 178. North America Montelukast Drug Revenue by Application (2021-2026) & (US$ Million) Table 179. North America Montelukast Drug Revenue by Application (2027-2032) & (US$ Million) Table 180. North America Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 181. North America Montelukast Drug Sales by Application (2027-2032) & (W Units) Table 182. North America Montelukast Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 183. North America Montelukast Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 184. North America Montelukast Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. North America Montelukast Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. North America Montelukast Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. North America Montelukast Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 188. North America Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 189. North America Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 190. North America Montelukast Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 191. North America Montelukast Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 192. United States Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 193. Canada Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 194. Europe Montelukast Drug Revenue by Type (2021-2026) & (US$ Million) Table 195. Europe Montelukast Drug Revenue by Type (2027-2032) & (US$ Million) Table 196. Europe Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 197. Europe Montelukast Drug Sales by Type (2027-2032) & (W Units) Table 198. Europe Montelukast Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 199. Europe Montelukast Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 200. Europe Montelukast Drug Revenue by Application (2021-2026) & (US$ Million) Table 201. Europe Montelukast Drug Revenue by Application (2027-2032) & (US$ Million) Table 202. Europe Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 203. Europe Montelukast Drug Sales by Application (2027-2032) & (W Units) Table 204. Europe Montelukast Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 205. Europe Montelukast Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Europe Montelukast Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Europe Montelukast Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Europe Montelukast Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Europe Montelukast Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 210. Europe Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 211. Europe Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 212. Europe Montelukast Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 213. Europe Montelukast Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Germany Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 215. France Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 216. U.K. Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 217. Italy Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 218. Netherlands Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 219. China Montelukast Drug Revenue by Type (2021-2026) & (US$ Million) Table 220. China Montelukast Drug Revenue by Type (2027-2032) & (US$ Million) Table 221. China Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 222. China Montelukast Drug Sales by Type (2027-2032) & (W Units) Table 223. China Montelukast Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 224. China Montelukast Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 225. China Montelukast Drug Revenue by Application (2021-2026) & (US$ Million) Table 226. China Montelukast Drug Revenue by Application (2027-2032) & (US$ Million) Table 227. China Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 228. China Montelukast Drug Sales by Application (2027-2032) & (W Units) Table 229. China Montelukast Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 230. China Montelukast Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 231. Asia Montelukast Drug Revenue by Type (2021-2026) & (US$ Million) Table 232. Asia Montelukast Drug Revenue by Type (2027-2032) & (US$ Million) Table 233. Asia Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 234. Asia Montelukast Drug Sales by Type (2027-2032) & (W Units) Table 235. Asia Montelukast Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 236. Asia Montelukast Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 237. Asia Montelukast Drug Revenue by Application (2021-2026) & (US$ Million) Table 238. Asia Montelukast Drug Revenue by Application (2027-2032) & (US$ Million) Table 239. Asia Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 240. Asia Montelukast Drug Sales by Application (2027-2032) & (W Units) Table 241. Asia Montelukast Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 242. Asia Montelukast Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 243. Asia Montelukast Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 244. Asia Montelukast Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 245. Asia Montelukast Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 246. Asia Montelukast Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 247. Asia Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 248. Asia Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 249. Asia Montelukast Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 250. Asia Montelukast Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 251. Japan Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 252. South Korea Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 253. India Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 254. Australia Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 255. China Taiwan Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 256. Southeast Asia Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 257. SAMEA Montelukast Drug Revenue by Type (2021-2026) & (US$ Million) Table 258. SAMEA Montelukast Drug Revenue by Type (2027-2032) & (US$ Million) Table 259. SAMEA Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 260. SAMEA Montelukast Drug Sales by Type (2027-2032) & (W Units) Table 261. SAMEA Montelukast Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 262. SAMEA Montelukast Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 263. SAMEA Montelukast Drug Revenue by Application (2021-2026) & (US$ Million) Table 264. SAMEA Montelukast Drug Revenue by Application (2027-2032) & (US$ Million) Table 265. SAMEA Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 266. SAMEA Montelukast Drug Sales by Application (2027-2032) & (W Units) Table 267. SAMEA Montelukast Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 268. SAMEA Montelukast Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 269. SAMEA Montelukast Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 270. SAMEA Montelukast Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 271. SAMEA Montelukast Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 272. SAMEA Montelukast Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 273. SAMEA Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 274. SAMEA Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 275. SAMEA Montelukast Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 276. SAMEA Montelukast Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 277. Brazil Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 278. Argentina Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 279. Chile Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 280. Colombia Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 281. Peru Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 282. Saudi Arabia Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 283. Israel Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 284. UAE Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 285. Turkey Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 286. Iran Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 287. Egypt Montelukast Drug Revenue (2021-2032) & (US$ Million) Table 288. Key Raw Materials Table 289. Raw Materials Key Suppliers Table 290. Montelukast Drug Distributors List Table 291. Montelukast Drug Customers List Table 292. Research Programs/Design for This Report Table 293. Authors List of This Report Table 294. Secondary Sources Table 295. Primary Sources List of Figures Figure 1. Montelukast Drug Image Figure 2. Global Montelukast Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Oral Granules Image Figure 6. Global Montelukast Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Montelukast Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug Store Image Figure 10. Others Image Figure 11. Global Montelukast Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Montelukast Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global Montelukast Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Montelukast Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Montelukast Drug Revenue Market Share by Region (2021-2032) Figure 16. Global Montelukast Drug Sales (2021-2032) & (W Units) Figure 17. Global Montelukast Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 18. Global Montelukast Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Montelukast Drug Sales YoY (2021-2032) & (W Units) Figure 20. Europe Montelukast Drug Sales YoY (2021-2032) & (W Units) Figure 21. China Montelukast Drug Sales YoY (2021-2032) & (W Units) Figure 22. Asia (Excluding China) Montelukast Drug Sales YoY (2021-2032) & (W Units) Figure 23. South America, Middle East and Africa Montelukast Drug Sales YoY (2021-2032) & (W Units) Figure 24. Global Montelukast Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Montelukast Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Montelukast Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Montelukast Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Montelukast Drug Revenue Market Share by Type (2021-2032) Figure 30. Global Montelukast Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 31. Global Montelukast Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Montelukast Drug Sales Market Share by Type (2021-2032) Figure 33. Global Montelukast Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Montelukast Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Montelukast Drug Revenue Market Share by Application (2021-2032) Figure 36. Global Montelukast Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Montelukast Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Montelukast Drug Sales Market Share by Application (2021-2032) Figure 39. North America Montelukast Drug Revenue Share by Type (2021-2032) Figure 40. North America Montelukast Drug Sales Share by Type (2021-2032) Figure 41. North America Montelukast Drug Revenue Share by Application (2021-2032) Figure 42. North America Montelukast Drug Sales Share by Application (2021-2032) Figure 43. North America Montelukast Drug Revenue Share by Country (2021-2032) Figure 44. North America Montelukast Drug Sales Share by Country (2021-2032) Figure 45. Europe Montelukast Drug Revenue Share by Type (2021-2032) Figure 46. Europe Montelukast Drug Sales Share by Type (2021-2032) Figure 47. Europe Montelukast Drug Revenue Share by Application (2021-2032) Figure 48. Europe Montelukast Drug Sales Share by Application (2021-2032) Figure 49. Europe Montelukast Drug Revenue Share by Country (2021-2032) Figure 50. Europe Montelukast Drug Sales Share by Country (2021-2032) Figure 51. China Montelukast Drug Revenue Share by Type (2021-2032) Figure 52. China Montelukast Drug Sales Share by Type (2021-2032) Figure 53. China Montelukast Drug Revenue Share by Application (2021-2032) Figure 54. China Montelukast Drug Sales Share by Application (2021-2032) Figure 55. Asia Montelukast Drug Revenue Share by Type (2021-2032) Figure 56. Asia Montelukast Drug Sales Share by Type (2021-2032) Figure 57. Asia Montelukast Drug Revenue Share by Application (2021-2032) Figure 58. Asia Montelukast Drug Sales Share by Application (2021-2032) Figure 59. Asia Montelukast Drug Revenue Share by Country (2021-2032) Figure 60. Asia Montelukast Drug Sales Share by Country (2021-2032) Figure 61. SAMEA Montelukast Drug Revenue Share by Type (2021-2032) Figure 62. SAMEA Montelukast Drug Sales Share by Type (2021-2032) Figure 63. SAMEA Montelukast Drug Revenue Share by Application (2021-2032) Figure 64. SAMEA Montelukast Drug Sales Share by Application (2021-2032) Figure 65. SAMEA Montelukast Drug Revenue Share by Country (2021-2032) Figure 66. SAMEA Montelukast Drug Sales Share by Country (2021-2032) Figure 67. Montelukast Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Montelukast Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Granules
Applications
  • Hospital
  • Drug Store
  • Others
Companies covered
  • Teva
  • Sandoz
  • Merck & Co.
  • Mylan
  • Unimark
  • Unichem Laboratories
  • Torrent Pharmaceuticals
  • Shanghai Anbison Lab
  • Perrigo
  • MACLEODS
  • Lannett Company
  • Jubilant Pharma
  • Hikma Group
  • Hetero
  • Glenmark Pharmaceuticals
  • Dr. Reddys Laboratories
  • CSPC Ouyi Pharmaceutical
  • Cipla
  • Aurobindo Pharma
  • Apotex
  • Amneal Pharmaceuticals
  • Ajanta Pharma
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Montelukast Drug Market by Type
  3. 1.2.1 Global Montelukast Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablets
  5. 1.2.3 Oral Granules
  6. 1.3 Montelukast Drug Market by Application
  7. 1.3.1 Global Montelukast Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug Store
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Montelukast Drug Market Dynamics
  1. 2.1 Montelukast Drug Industry Trends
  2. 2.2 Montelukast Drug Industry Drivers
  3. 2.3 Montelukast Drug Industry Opportunities and Challenges
  4. 2.4 Montelukast Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Montelukast Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Montelukast Drug Revenue by Region
  3. 3.2.1 Global Montelukast Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Montelukast Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Montelukast Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Montelukast Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Montelukast Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Montelukast Drug Sales by Region
  9. 3.4.1 Global Montelukast Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Montelukast Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Montelukast Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Montelukast Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Montelukast Drug Revenue by Manufacturers
  2. 4.1.1 Global Montelukast Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Montelukast Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Montelukast Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Montelukast Drug Sales by Manufacturers
  6. 4.2.1 Global Montelukast Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Montelukast Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Montelukast Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Montelukast Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Montelukast Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Montelukast Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Montelukast Drug Manufacturers, Product Type & Application
  13. 4.7 Global Montelukast Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Montelukast Drug Market CR5 and HHI
  16. 4.8.2 2025 Montelukast Drug Tier 1, Tier 2, and Tier 3
5 Montelukast Drug Market by Type
  1. 5.1 Global Montelukast Drug Revenue by Type
  2. 5.1.1 Global Montelukast Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Montelukast Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Montelukast Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Montelukast Drug Sales by Type
  6. 5.2.1 Global Montelukast Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Montelukast Drug Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Montelukast Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Montelukast Drug Price by Type
6 Montelukast Drug Market by Application
  1. 6.1 Global Montelukast Drug Revenue by Application
  2. 6.1.1 Global Montelukast Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Montelukast Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Montelukast Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Montelukast Drug Sales by Application
  6. 6.2.1 Global Montelukast Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Montelukast Drug Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Montelukast Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Montelukast Drug Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Montelukast Drug Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sandoz
  8. 7.2.1 Sandoz Company Information
  9. 7.2.2 Sandoz Business Overview
  10. 7.2.3 Sandoz Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sandoz Montelukast Drug Product Portfolio
  12. 7.2.5 Sandoz Recent Developments
  13. 7.3 Merck & Co.
  14. 7.3.1 Merck & Co. Company Information
  15. 7.3.2 Merck & Co. Business Overview
  16. 7.3.3 Merck & Co. Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck & Co. Montelukast Drug Product Portfolio
  18. 7.3.5 Merck & Co. Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Montelukast Drug Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Unimark
  26. 7.5.1 Unimark Company Information
  27. 7.5.2 Unimark Business Overview
  28. 7.5.3 Unimark Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Unimark Montelukast Drug Product Portfolio
  30. 7.5.5 Unimark Recent Developments
  31. 7.6 Unichem Laboratories
  32. 7.6.1 Unichem Laboratories Company Information
  33. 7.6.2 Unichem Laboratories Business Overview
  34. 7.6.3 Unichem Laboratories Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Unichem Laboratories Montelukast Drug Product Portfolio
  36. 7.6.5 Unichem Laboratories Recent Developments
  37. 7.7 Torrent Pharmaceuticals
  38. 7.7.1 Torrent Pharmaceuticals Company Information
  39. 7.7.2 Torrent Pharmaceuticals Business Overview
  40. 7.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Torrent Pharmaceuticals Montelukast Drug Product Portfolio
  42. 7.7.5 Torrent Pharmaceuticals Recent Developments
  43. 7.8 Shanghai Anbison Lab
  44. 7.8.1 Shanghai Anbison Lab Company Information
  45. 7.8.2 Shanghai Anbison Lab Business Overview
  46. 7.8.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Shanghai Anbison Lab Montelukast Drug Product Portfolio
  48. 7.8.5 Shanghai Anbison Lab Recent Developments
  49. 7.9 Perrigo
  50. 7.9.1 Perrigo Company Information
  51. 7.9.2 Perrigo Business Overview
  52. 7.9.3 Perrigo Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Perrigo Montelukast Drug Product Portfolio
  54. 7.9.5 Perrigo Recent Developments
  55. 7.10 MACLEODS
  56. 7.10.1 MACLEODS Company Information
  57. 7.10.2 MACLEODS Business Overview
  58. 7.10.3 MACLEODS Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 MACLEODS Montelukast Drug Product Portfolio
  60. 7.10.5 MACLEODS Recent Developments
  61. 7.11 Lannett Company
  62. 7.11.1 Lannett Company Company Information
  63. 7.11.2 Lannett Company Business Overview
  64. 7.11.3 Lannett Company Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Lannett Company Montelukast Drug Product Portfolio
  66. 7.11.5 Lannett Company Recent Developments
  67. 7.12 Jubilant Pharma
  68. 7.12.1 Jubilant Pharma Company Information
  69. 7.12.2 Jubilant Pharma Business Overview
  70. 7.12.3 Jubilant Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Jubilant Pharma Montelukast Drug Product Portfolio
  72. 7.12.5 Jubilant Pharma Recent Developments
  73. 7.13 Hikma Group
  74. 7.13.1 Hikma Group Company Information
  75. 7.13.2 Hikma Group Business Overview
  76. 7.13.3 Hikma Group Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hikma Group Montelukast Drug Product Portfolio
  78. 7.13.5 Hikma Group Recent Developments
  79. 7.14 Hetero
  80. 7.14.1 Hetero Company Information
  81. 7.14.2 Hetero Business Overview
  82. 7.14.3 Hetero Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Hetero Montelukast Drug Product Portfolio
  84. 7.14.5 Hetero Recent Developments
  85. 7.15 Glenmark Pharmaceuticals
  86. 7.15.1 Glenmark Pharmaceuticals Company Information
  87. 7.15.2 Glenmark Pharmaceuticals Business Overview
  88. 7.15.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Glenmark Pharmaceuticals Montelukast Drug Product Portfolio
  90. 7.15.5 Glenmark Pharmaceuticals Recent Developments
  91. 7.16 Dr. Reddys Laboratories
  92. 7.16.1 Dr. Reddys Laboratories Company Information
  93. 7.16.2 Dr. Reddys Laboratories Business Overview
  94. 7.16.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Dr. Reddys Laboratories Montelukast Drug Product Portfolio
  96. 7.16.5 Dr. Reddys Laboratories Recent Developments
  97. 7.17 CSPC Ouyi Pharmaceutical
  98. 7.17.1 CSPC Ouyi Pharmaceutical Company Information
  99. 7.17.2 CSPC Ouyi Pharmaceutical Business Overview
  100. 7.17.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolio
  102. 7.17.5 CSPC Ouyi Pharmaceutical Recent Developments
  103. 7.18 Cipla
  104. 7.18.1 Cipla Company Information
  105. 7.18.2 Cipla Business Overview
  106. 7.18.3 Cipla Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Cipla Montelukast Drug Product Portfolio
  108. 7.18.5 Cipla Recent Developments
  109. 7.19 Aurobindo Pharma
  110. 7.19.1 Aurobindo Pharma Company Information
  111. 7.19.2 Aurobindo Pharma Business Overview
  112. 7.19.3 Aurobindo Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Aurobindo Pharma Montelukast Drug Product Portfolio
  114. 7.19.5 Aurobindo Pharma Recent Developments
  115. 7.20 Apotex
  116. 7.20.1 Apotex Company Information
  117. 7.20.2 Apotex Business Overview
  118. 7.20.3 Apotex Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Apotex Montelukast Drug Product Portfolio
  120. 7.20.5 Apotex Recent Developments
  121. 7.21 Amneal Pharmaceuticals
  122. 7.21.1 Amneal Pharmaceuticals Company Information
  123. 7.21.2 Amneal Pharmaceuticals Business Overview
  124. 7.21.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Amneal Pharmaceuticals Montelukast Drug Product Portfolio
  126. 7.21.5 Amneal Pharmaceuticals Recent Developments
  127. 7.22 Ajanta Pharma
  128. 7.22.1 Ajanta Pharma Company Information
  129. 7.22.2 Ajanta Pharma Business Overview
  130. 7.22.3 Ajanta Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Ajanta Pharma Montelukast Drug Product Portfolio
  132. 7.22.5 Ajanta Pharma Recent Developments
  133. 7.23 Accord Healthcare
  134. 7.23.1 Accord Healthcare Company Information
  135. 7.23.2 Accord Healthcare Business Overview
  136. 7.23.3 Accord Healthcare Montelukast Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Accord Healthcare Montelukast Drug Product Portfolio
  138. 7.23.5 Accord Healthcare Recent Developments
8 North America
  1. 8.1 North America Montelukast Drug Market Size by Type
  2. 8.1.1 North America Montelukast Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Montelukast Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Montelukast Drug Price by Type (2021-2032)
  5. 8.2 North America Montelukast Drug Market Size by Application
  6. 8.2.1 North America Montelukast Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Montelukast Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Montelukast Drug Price by Application (2021-2032)
  9. 8.3 North America Montelukast Drug Market Size by Country
  10. 8.3.1 North America Montelukast Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Montelukast Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Montelukast Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Montelukast Drug Market Size by Type
  2. 9.1.1 Europe Montelukast Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Montelukast Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Montelukast Drug Price by Type (2021-2032)
  5. 9.2 Europe Montelukast Drug Market Size by Application
  6. 9.2.1 Europe Montelukast Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Montelukast Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Montelukast Drug Price by Application (2021-2032)
  9. 9.3 Europe Montelukast Drug Market Size by Country
  10. 9.3.1 Europe Montelukast Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Montelukast Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Montelukast Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Montelukast Drug Market Size by Type
  2. 10.1.1 China Montelukast Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Montelukast Drug Sales by Type (2021-2032)
  4. 10.1.3 China Montelukast Drug Price by Type (2021-2032)
  5. 10.2 China Montelukast Drug Market Size by Application
  6. 10.2.1 China Montelukast Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Montelukast Drug Sales by Application (2021-2032)
  8. 10.2.3 China Montelukast Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Montelukast Drug Market Size by Type
  2. 11.1.1 Asia Montelukast Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Montelukast Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Montelukast Drug Price by Type (2021-2032)
  5. 11.2 Asia Montelukast Drug Market Size by Application
  6. 11.2.1 Asia Montelukast Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Montelukast Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Montelukast Drug Price by Application (2021-2032)
  9. 11.3 Asia Montelukast Drug Market Size by Country
  10. 11.3.1 Asia Montelukast Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Montelukast Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Montelukast Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Montelukast Drug Market Size by Type
  2. 12.1.1 SAMEA Montelukast Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Montelukast Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Montelukast Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Montelukast Drug Market Size by Application
  6. 12.2.1 SAMEA Montelukast Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Montelukast Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Montelukast Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Montelukast Drug Market Size by Country
  10. 12.3.1 SAMEA Montelukast Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Montelukast Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Montelukast Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Montelukast Drug Value Chain Analysis
  2. 13.1.1 Montelukast Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Montelukast Drug Production Mode & Process
  6. 13.2 Montelukast Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Montelukast Drug Distributors
  9. 13.2.3 Montelukast Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst